Subtotal: R8 700,00
PHARMA Duro 30 (30pc)
R650,00
DUROMINE may appropriately be initiated in overweight patients with a lower BMI when risk of
morbidity from other medical conditions is increased. P
Guarantee safe & secure checkout
On all order
Description
DUROMINE may appropriately be initiated in overweight patients with a lower BMI when risk of
morbidity from other medical conditions is increased.
Quick Comparison
| PHARMA Duro 30 (30pc) remove | BP BPC157 & TB500 remove | BP Semag 6 remove | NOVA Glutathione remove | NOVA Mito Boost remove | HDL Semag 10 remove | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | PHARMA Duro 30 (30pc) remove | BP BPC157 & TB500 remove | BP Semag 6 remove | NOVA Glutathione remove | NOVA Mito Boost remove | HDL Semag 10 remove | ||||||||||
| Image | |  | | | | | ||||||||||
| SKU | IN_LK | IN_LK-5 | IN_LK-19 | IN_LK-23 | IN_LK-11 | |||||||||||
| Rating | ||||||||||||||||
| Price | R650,00 | R2 200,00 | R2 500,00 | R1 500,00 | R1 050,00 | R1 450,00 | ||||||||||
| Stock | ||||||||||||||||
| Weight | N/A | N/A | N/A | N/A | N/A | N/A | ||||||||||
| Dimensions | N/A | N/A | N/A | N/A | N/A | N/A | ||||||||||
| Additional information |
|
|
|
|
| |||||||||||
| Description | DUROMINE may appropriately be initiated in overweight patients with a lower BMI when risk of morbidity from other medical conditions is increased. P | This blend combines two well-studied regenerative peptides: BPC-157 (Body Protection Compound-157), a pentadecapeptide derived from human gastric juice with cytoprotective and wound-healing properties[1][2], and TB-500 (Thymosin Beta-4 fragment), a 43-amino-acid peptide involved in tissue repair, cell migration, and angiogenesis[3][4]. |
| Glutathione is often called the master antioxidant — and for good reason. This powerful tripeptide is your body’s ultimate detoxifier, immune booster, and cellular protector. | Mito Boost is a high-potency MOTS-c peptide pen designed to optimise mitochondrial function. It works at a cellular level to enhance energy production, endurance, recovery, and overall longevity. | Semaglutide activates the GLP-1 (glucagon-like peptide-1) receptor, producing multiple downstream effects: enhanced insulin secretion in response to meals, suppressed glucagon output, delayed gastric emptying, and reduced appetite signals. | ||||||||||
| Add to cart |
